Empathic Communication Skills (ECS) Training
Sponsored by Memorial Sloan Kettering Cancer Center
About this study
Research indicates that perceived stigma within medical encounters is prevalent and problematic for lung cancer patients' well-being and quality of cancer care. Promoting empathic communication appears to be a potentially effective intervention target to help reduce patients' perceptions of stigma within clinical encounters; however, no formal trainings exist that focus on teaching empathic communication to oncology care providers (OCPs). Building upon favorable findings from a prior R21 (R21CA202793) and the importance of developing interventions to address lung cancer stigma, our goal is to conduct a national trial of empathic communication skills (ECS) training to facilitate improvements in the medical and psychosocial care of patients through de-stigmatizing interactions with OCPs for patients diagnosed with lung cancer.
The aims of this study are: 1. to evaluate the effect of the ECS training on OCP primary outcomes (communication and empathic skill uptake) and secondary outcomes (ECS training appraisal - relevance, novelty, clarity; self-efficacy, empathy, compassion burn-out); 2. to evaluate the effect of the ECS training vs. WLC on patients' reported primary outcomes (lung cancer stigma), and secondary outcomes (perceived clinician empathy, satisfaction with communication, psychological distress, patients' experience of clinical encounter, and overall patient satisfaction). Additionally, acceptance of referral to tobacco cessation (for those currently smoking) will be explored; and 3. to examine potential moderators of OCP (e.g., demographic characteristics, professional role characteristics) and …
Where this study is enrolling (8)
- Call 786-596-2000
BAPTIST ALLIANCE - MCI (Data Collection Only)
Miami, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 847-367-6781
Advocate Health Care Network
Libertyville, Illinois
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 551-996-8704
Hackensack Meridian Health (Data collection only)
Hackensack, New Jersey
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 716-845-2300
Roswell Park Cancer Institute (Data Collection Only)
Buffalo, New York
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 646-888-0011
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
Show all 8 locations
- I'm interested
University of Pennsylvania (Data Collection Only)
Philadelphia, Pennsylvania
- I'm interested
Fox Chase Cancer Center (Data Collection Only)
Philadelphia, Pennsylvania
- Call 757-842-4499
Chesapeake Regional Healthcare (Data Collection Only)
Chesapeake, Virginia
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
Who can participate
Inclusion criteria
- ✓Site Eligibility
- ✓Employs at least 15 FTE OCPs (i.e., oncologists, nurse practitioners and physician assistants) as per self report
- ✓Reports a clinic volume of at least 20 new lung cancer patients per month as per self report
- ✓OCP Participant Eligibility
- ✓OCPs who are thoracic oncology physicians (radiologists, medical oncologists, pulmonologists, and surgeons), NPs, or PAs and currently treating lung cancer patients, as per self-report;
- ✓OCP conducts consultations with lung cancer patients, as per self-report;
- ✓OCP sees at least 1 lung cancer patient per week, as per self-report;
- ✓Patient Eligibility
- ✓Patient under the care of a participating OCP as per self report;
- ✓English and/or Spanish speaking;
- ✓In general, which language do you prefer to receive your medical care, English/Spanish/both English and Spanish Equally?
- ✓If English, treat as fluent in English, no additional language questions
- ✓If Spanish, treat as fluent in Spanish, no additional language questions
- ✓If both English and Spanish equally, ask the follow-up questions and go with whichever language is endorsed as best. If endorsed equally, assign to category patient prefers
- ✓How well do you speak English? Not at all/ Not well/Well/Very well
- ✓How well do you speak Spanish? Not at all/Not well/Well/Very well
- ✓Is at least 18 years of age as per self report;
- ✓Has a history of suspicious lung mass or confirmed lung cancer diagnosis, as per clinician judgment or medical record note;
- ✓Is a former or current smoking as per self report;
- ✓Has had no more than 10 prior visits with the participating OCP, as per the medical record and/or self report
Exclusion criteria
- ✕Patient Exclusion
- ✕Individuals of impaired decision-making capacity as per a clinician's judgment or as documented in the EMR.
- ✕Site and OCP Exclusion
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.